Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in LYEL — Lyell Immunopharma, Inc.

CIK 73124 CHICAGO, IL
Back to LYEL Full portfolio

Position in LYEL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,664,924
+$1,057,508 QoQ
Shares Held
118,500
+291.3% QoQ
Ownership
0.484%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 87 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 99% Shared 1% None 0%

Common Shares in LYEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. LYEL ranks #240 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in LYEL

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,664,924 118,500
2026-03-31 $607,416 30,280
2025-12-31 $932,017 30,280
2025-09-30 $456,798 28,128
2025-06-30 $164,812 18,644
2025-03-31 $696,747 1,295,073
2024-12-31 $838,542 1,310,224
2024-09-30 $1,871,385 1,356,077
2024-06-30 $2,014,108 1,389,041
2024-03-31 $3,215,591 1,441,970
2023-12-31 $2,862,485 1,475,509
2023-09-30 $2,180,270 1,483,178
2023-06-30 $4,560,943 1,434,259
2023-03-31 $4,084,630 1,730,776
2022-12-31 $7,594,229 2,188,539
2022-09-30 $14,943,794 2,038,717
2022-06-30 $7,851,853 1,204,272
2022-03-31 $5,314,669 1,052,410
2021-12-31 $1,637,605 211,577
2021-09-30 $3,164,891 213,844